Tools to Access the Latest Cancer Statistics Paul Miller Washington Reporting Fellowships program presentation April 15, 2013.

Slides:



Advertisements
Similar presentations
Using Cancer Registry Data for Comprehensive Cancer Control Christie Eheman, PhD, National Program of Cancer Registries, Division of Cancer Prevention.
Advertisements

Preventing Cancer with Healthy Life Styles Li-Fen L. Chang, M.D., Ph.D. Radiation Oncology SOMC Cancer Center.
National Institute of Oncology Rabat-Morocco. National Institute of Oncology I.N.O. Rabat, Morocco : New Cases.
Professor of Hematology, Oncology, Medicine and Epidemiology
BMP receptor1a Amit Patel Estimated US Cancer Deaths* ONS=Other nervous system. Source: American Cancer Society, Men 295,280 Women 275,000.
April 6, o What is cancer? o Cancer statistics o Cancer prevention and early detection o Cancer disparities o Cancer survivorship o Cancer research.
Tuesday, June 23, Today’s discussion General cancer statistics Cancer in Canada PEI Statistics at a glance Impact.
1 Cancer PREVENTION “Take charge of your life and learn as much as you can about illness. Knowledge generates hope.” Lance Armstrong Winner of 6 Tour de.
Dietary intakes of calcium and vitamin D and risk of colorectal cancer in women Jennifer Lin, PhD Division of Preventive Medicine Brigham and Women’s Hospital.
Cancer and Minorities Norma Kanarek, MPH, PhD Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health Department of.
* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical.
Racial/Ethnic Disparities in Cancer Incidence, Survival and Treatment Linda C. Harlan, PhD, MPH National Cancer Institute Division of Cancer Control and.
MOLLY SCHWENN, MD CANCER REGISTRY MAINE CDC, DHHS OCTOBER 25, 2013 Population-based Cancer Surveillance: State Perspective.
Epidemiology of Oral Cancer Module 1:. Epidemiology of Cancer, U.S.
Overview of All SEER-Medicare Publications Through 2012 Mark D. Danese, MHS, PhD July 24, 2012.
Cervical Cancer in California Janet Bates, MD MPH Research Program Director Research and Surveillance Program California Cancer Registry.
* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical.
BIOE 301 Lecture Twelve Jair Martinez Bioengineering Department Rice University.
Cancer Incidence and Mortality in Massachusetts, Bureau of Health Statistics, Research and Evaluation Massachusetts Department of Public Health.
Health Consultation: Evaluation of Cancer Incidence in Census Tracts of Attleboro and Norton, Massachusetts: Suzanne K. Condon Associate Commissioner.
Women’s Health in Massachusetts Highlights from the Massachusetts Behavioral Risk Factor Surveillance System (BRFSS): Health Survey Program Bureau.
Cancer Among Native Americans in Arizona and New Mexico Data Provided by Arizona Cancer Registry at the Arizona Department of Health Services and the New.
INCIDENCE AND SURVIVAL TRENDS OF COLORECTAL CANCER FROM 2002 TO 2011 BE Ansa; E Alema-Mensah; MD Claridy; JQ Sheats; B Fontenot, and SA Smith Georgia Regents.
Cancer Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
US Cancer Burden Epi 242 Cancer Epidemiology Binh Goldstein, Ph.D. October 7, 2009.
CANCER INCIDENCE IN NEW JERSEY BY COUNTY, for the Comprehensive Cancer Control Plan County Needs Assessments August 2003 Prepared by: Cancer.
Regulating the Cell Cycle Biology 392 Chapter 10-3.
Breast Cancer: Treatment or Not? HFE 742 Cathy Simmons November 10, 2005.
“The African American Prostate Cancer Crisis in Numbers”
A Glimpse of the Science Behind the American Cancer Society Access to Care Campaign Impact of Being Uninsured or Underinsured on Individuals with Cancer.
WE WILL ALL DIE OF CANCER If something else doesn’t kill us first HYPOTHESIS:
Alaska Native Tumor Registry Alaska Native Epidemiology Center 40-Year Trends in Cancer Incidence among Alaska Native People
HEAD/NECK OF THE SKIN ANALYTIC vs. NON-ANALYTIC by YEAR N = 1800.
Slides last updated: October Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality.
Role of the Surgeon in Cancer Management A. Responsible for the initial diagnosis and management of solid tumors. B. Responsible for the Definitive Surgical.
Data Sources-Cancer Betsy A. Kohler, MPH, CTR Director, Cancer Epidemiology Services New Jersey Department of Health and Senior Services.
Associated Web sites CustomizableMaps The Atlas On-Line.
Prostate Cancer Outcomes by Race & Treatment Site Can-lan Sun MD PhD, Smita Bhatia MD MPH, Lennie Wong PhD, Gail Washington DNS, Karen Nielsen-Menicucci.
The Genetic Component of a Common Disease The Paradigm of Cancer Genetics John Quillin, PhD, MPH, MS Virginia Commonwealth University Fall, 2005.
The Genetic Component of a Common Disease The Paradigm of Cancer Genetics John Quillin, PhD, MPH, MS Virginia Commonwealth University Summer, 2006.
Bioengineering and World Health Lecture Twelve. Four Questions What are the major health problems worldwide? Who pays to solve problems in health care?
Homework #3 is due 11/19 Bonus #2 is posted. Cancer: is the loss of control over cell division. Tumors are normal cells that are dividing inappropriately.
Breast cancer affects 1 in 8 women during their lives. 1 Population Statistics.
SEER Data Cancer Project Brett Langsjoen. SEER Surveillance, Epidemiology, and End Results Program of the National Cancer Institute (NCI) Purpose: Collect.
Gender & Non-Gender Specific Cancer. Quick Facts On average, 386 Canadian men will be diagnosed with prostate cancer every week. On average, 407 Canadian.
Slides last updated: March Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN.
Riva L. Rahl, M.D. Cooper Clinic Preventive Medicine Physician Medical Director, Cooper Wellness Program Cancer: Beating the Odds.
Cancer: causes abnormal and uncontrolled cell growth to occur within body Because cancer cells continue to grow and divide, they are different from normal.
Cancer in Ontario: Overview A Statistical Report.
Premature deaths due to Prostate Cancer: The Role of Diagnosis and Treatment Appathurai Balamurugan MD, MPH S William Ross MD Chris Fisher, BS Jim Files,
What is cancer?. Cancer Development of abnormal cells Divide uncontrollably Can infiltrate and destroy normal body tissue.
Indiana State Cancer Registry
2 Incidence SABER This module presents statistics from Chapter 2: Incidence Ontario Cancer Statistics 2016 Chapter 2: Incidence.
Cervical Cancer in California
US Mortality, 2003 No. of deaths % of all deaths Rank Cause of Death
5 Prevalence ZEINAB This module presents statistics from Chapter 5: Prevalence Ontario Cancer Statistics 2016 Chapter 5: Prevalence.
Non-Communicable Diseases Lesson 7
2 Incidence Ontario Cancer Statistics 2016 Chapter 2: Incidence.
Cancer Epidemiology Kara P. Wiseman, MPH, Phd
Bronx Community Health Dashboard: Other Cancers Last Updated: 01/09/2018 See last slide for more information about this project.
5 Prevalence Ontario Cancer Statistics 2016 Chapter 5: Prevalence.
Estimated current cancer incidence
National Cancer Statistics in Korea, 2015
Citation: Cancer Care Ontario
Andrea Sipin-Baliwas Los Angeles Cancer Surveillance Program
Presentation transcript:

Tools to Access the Latest Cancer Statistics Paul Miller Washington Reporting Fellowships program presentation April 15, 2013

SEER area, funded by NCI SEER/NPCR* area, funded by NCI and CDC NPCR area, funded by CDC *NPCR – National Program of Cancer Registries Surveillance, Epidemiology, and End Results (SEER) Program: Cancer Registries and Collaborators

The SEER Program  SEER collects data on cancer incidence and survival, calculates prevalence, and compiles these statistics, plus also reports mortality data.  NCI’s Surveillance Research Program (SRP) reports data collected by SEER in the Cancer Statistics Review and other publications made available to reporters and the public. It is usually updated every April 15. This year’s update will cover the period from  Data is also available through SEER tools and resources, such as SEER*Stat software and linked data files. Requests are hand- processed.

Annual Report to the Nation on the Status of Cancer NCI partners on the “The Annual Report to the Nation on the Status of Cancer” with CDC, the American Cancer Society, and the North American Association of Central Cancer Registries. The most recent Annual Report to the Nation appeared in JNCI on Jan. 7, 2013, with a special section on Human Papilloma Virus (HPV) surveillance. The next Annual Report, covering the time period , should appear early in 2014.

SEER Cancer Stat Fact Sheet Cancer Stat Fact Sheets provide statistical summaries for 30 cancer sites, including for “All Cancer Sites.” seer.cancer.gov/statfacts/ Cancer Stat Fact Sheets provide statistical summaries for 30 cancer sites, including for “All Cancer Sites.” seer.cancer.gov/statfacts/

Cancer Stat Fact Sheet: All Cancer Sites  For each fact sheet, statistics may include Incidence & Mortality, Survival, Lifetime Risk, and Prevalence.  These are updated annually to coincide with SEER data release.  For each fact sheet, statistics may include Incidence & Mortality, Survival, Lifetime Risk, and Prevalence.  These are updated annually to coincide with SEER data release.

Cancer Stat Fact Sheet: All Cancer Sites SEER Incidence SEER Incidence  Incidence is the number of new cases of disease diagnosed each year.  The “age-adjusted” incidence rate for All Cancer Sites was per 100,000 people per year.  This is based on cases diagnosed in from 18 SEER geographic areas. SEER Incidence  Incidence is the number of new cases of disease diagnosed each year.  The “age-adjusted” incidence rate for All Cancer Sites was per 100,000 people per year.  This is based on cases diagnosed in from 18 SEER geographic areas.

Cancer Stat Fact Sheet: All Cancer Sites US Mortality US Mortality  US mortality is the number of deaths in a certain group of people in a certain period of time.  The “age-adjusted” death rate for All Cancer Sites was per 100,000 people per year.  This rate is based on patients who died in in the United States. US Mortality  US mortality is the number of deaths in a certain group of people in a certain period of time.  The “age-adjusted” death rate for All Cancer Sites was per 100,000 people per year.  This rate is based on patients who died in in the United States.

Cancer Stat Fact Sheet: All Cancer Sites Trends in Rates Trends in SEER Incidence Rates  Trends can be evaluated by the annual percent change (APC).  From 1998 to 2009 the APC for All Cancer Sites was This was a statistically significant decrease.  Joinpoint analyses are used to evaluate when changes in the trend occurred with the APC. Trends in SEER Incidence Rates  Trends can be evaluated by the annual percent change (APC).  From 1998 to 2009 the APC for All Cancer Sites was This was a statistically significant decrease.  Joinpoint analyses are used to evaluate when changes in the trend occurred with the APC.

Joinpoint Trends in SEER Incidence Rates, All Cancer Sites Joinpoint Trend in SEER Cancer Incidence  An asterisk after the APC indicates that the trend was statistically significant.  Negative estimate indicates that cancer incidence was decreasing in that time period. Joinpoint Trend in SEER Cancer Incidence  An asterisk after the APC indicates that the trend was statistically significant.  Negative estimate indicates that cancer incidence was decreasing in that time period.

Cancer Stat Fact Sheet: All Cancer Sites Survival Survival  These survival statistics are based on 5-year Relative Survival. Relative survival estimates the percentage of patients expected to survive their cancer at a least 5 years after diagnosis.  The overall 5-year relative survival rate for men and women was 65.4%.  This is based on cases diagnosed between from 18 SEER geographic areas.Survival  These survival statistics are based on 5-year Relative Survival. Relative survival estimates the percentage of patients expected to survive their cancer at a least 5 years after diagnosis.  The overall 5-year relative survival rate for men and women was 65.4%.  This is based on cases diagnosed between from 18 SEER geographic areas.

Cancer Stat Fact Sheet: All Cancer Sites Lifetime Risk Lifetime Risk  Lifetime Risk is an estimate of the percentage of patients who will be diagnosed with cancer in their lifetime.  Based on rates from , 41.2% of men and women born today will be diagnosed with cancer in their lifetime.  SEER also calculates the probability of developing cancer between two age groups. This is available in Fast Stats. Lifetime Risk  Lifetime Risk is an estimate of the percentage of patients who will be diagnosed with cancer in their lifetime.  Based on rates from , 41.2% of men and women born today will be diagnosed with cancer in their lifetime.  SEER also calculates the probability of developing cancer between two age groups. This is available in Fast Stats.

Cancer Stat Fact Sheet: All Cancer Sites Prevalence Prevalence  Prevalence is the number of people alive that have had a previous diagnosis of cancer.  On January 1, 2009, there were 12,553,337 men and women alive who had a history of cancer of all sites.Prevalence  Prevalence is the number of people alive that have had a previous diagnosis of cancer.  On January 1, 2009, there were 12,553,337 men and women alive who had a history of cancer of all sites.

Trends in SEER Incidence by Primary Cancer Site, Average Annual Percent Change Myeloma Brain & Other Nervous System Lung & Bronchus (Female) Urinary Bladder All Sites Except Lung & Bronchus All Cancer Sites Breast (Female) Esophagus Leukemia Stomach Ovary Cervix Uteri Prostate Lung & Bronchus (Male) Larynx Colon & Rectum Thyroid Liver & Intrahepatic Bile Duct Kidney & Renal Pelvis Melanoma of the Skin Pancreas Corpus & Uterus, NOS Hodgkin Lymphoma Testis Non-Hodgkin Lymphoma Oral Cavity & Pharynx * The APC is significantly different from zero (p<.05)

Trends in US Death Rates by Primary Cancer Site, Average Annual Percent Change Esophagus Brain & Other Nervous System Testis Lung & Bronchus (Female) Kidney & Renal Pelvis Leukemia Oral Cavity & Pharynx All Cancer Sites All Sites Except Lung & Bronchus Ovary Cervix Uteri Myeloma Breast (Female) Hodgkin Lymphoma Lung & Bronchus (Male) Larynx Colon & Rectum Non-Hodgkin Lymphoma Stomach Prostate Liver & Intrahepatic Bile Duct Thyroid Melanoma of the Skin Pancreas Corpus & Uterus, NOS Urinary Bladder * The APC is significantly different from zero (p<.05)

SEER Web Sites SEER Home Page ( Cancer Statistics ( – Fact Sheets – Cancer Statistics Review (CSR) – State Cancer Profiles Access to SEER Datasets and NCI Software to analyze data (

What is State Cancer Profiles?  Statistics for prioritizing cancer control activities  National, state, and local level data  Collaboration  CDC’s National Program of Cancer Registries (NPCR)  NCI’s Surveillance, Epidemiology and End Results Registries (SEER)

Available Data  Cancer incidence, mortality data and prevalence data  Latest data years currently available  2009 NCI SEER incidence (2010 coming soon)  2009 CDC NPCR incidence  2009 NCHS mortality  About 20 different cancer sites  Screening and risk factor data

State Cancer Profiles Usage Resource for:  Priority setting; planning  Implementing and assessing cancer control projects  Exposing health disparities  Comparing state cancer data with other states  Reviewing trends in cancer  Presentations, reports, proposals, training

Quick Profiles Support Data

Death Rate/Trend Comparison by Cancer

SCP: Screening and Risk Factors

Mammography by State

Mammography by Small Area Estimates

Demographic Data  Population: Age Groups  Population: Race Groups  Education  Income  Housing  Urban/Rural  Workforce: Unemployed  Poverty

Persons below Poverty

Coming Soon to State Cancer Profiles  Home Page  HINTS (Health Interview National Trends Survey)  Demographic data  Small Area Health Insurance Estimates

Questions Please visit: